Theodore Huizenga A.'s Insider Trades & SAST Disclosures

Show

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2025	9,392	51,232 (0%)	0%		0	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2025	5,632	5,632	-		-	Stock Option (Right to Buy)
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 42.10 per share.	01 Mar 2025	967	50,265 (0%)	0%	42.1	40,711	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.92 per share.	01 Mar 2025	141	50,124 (0%)	0%	42.9	6,052	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Gift of securities by or to the insider at price $ 0.00 per share.	10 Dec 2024	648	41,840 (0%)	0%		0	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Sep 2024	700	42,251 (0%)	0%		0	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 56.19 per share.	03 Sep 2024	91	41,551 (0%)	0%	56.2	5,113	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.29 per share.	16 Apr 2024	14	41,366 (0%)	0%	42.3	592	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2024	13,950	41,842 (0%)	0%		0	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2024	8,200	8,200	-		-	Stock Option (Right to Buy)
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2024	2,351	2,351	-		-	Stock Option (Right to Buy)
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 53.76 per share.	01 Mar 2024	341	41,380 (0%)	0%	53.8	18,332	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.69 per share.	01 Mar 2024	121	41,721 (0%)	0%	53.7	6,496	Common Stock
Ultragenyx Pharmaceutical ...	Huizenga Theodore A.	SVP, Chief Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Dec 2023	3,000	0	-		-	Stock Option (Right to Buy)
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.00 per share.	20 Dec 2023	3,000	27,892 (0%)	0%	21	63,000	Common Stock
Ultragenyx Pharmaceutical ...	Theodore Huizenga A.	SVP, Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Dec 2023	1,000	24,614 (0%)	0%		0	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.00 per share.	09 May 2023	3,000	30,747 (0%)	0%	21	63,000	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 May 2023	3,000	5,000	-		-	Stock Option (Right to Buy)
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Sale or transfer of securities back to the company at price $ 38.20 per share.	16 Apr 2023	181	27,520 (0%)	0%	38.2	6,914	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.21 per share.	16 Apr 2023	14	27,701 (0%)	0%	38.2	535	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2023	10,120	10,120	-		-	Stock Option (Right to Buy)
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2023	7,590	23,148 (0%)	0%		0	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Sale or transfer of securities back to the company at price $ 45.65 per share.	01 Mar 2023	1,333	21,715 (0%)	0%	45.6	60,851	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 45.65 per share.	01 Mar 2023	100	23,048 (0%)	0%	45.7	4,565	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 43.40 per share.	28 Feb 2023	639	15,558 (0%)	0%	43.4	27,733	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 43.96 per share.	21 Dec 2022	2,031	16,197 (0%)	0%	44.0	89,283	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Sep 2022	1,000	18,094 (0%)	0%		0	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 84.55 per share.	16 Apr 2022	132	16,914 (0%)	0%	84.6	11,161	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2022	7,400	7,400	-		-	Stock Option (Right to Buy)
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2022	3,710	17,046 (0%)	0%		0	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 66.62 per share.	01 Mar 2022	843	13,229 (0%)	0%	66.6	56,161	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Gift of securities by or to the insider at price $ 0.00 per share.	14 Oct 2021	819	14,212 (0%)	0%		0	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 81.14 per share.	14 Oct 2021	140	14,072 (0%)	0%	81.1	11,360	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 113.67 per share.	06 May 2021	142	15,031 (0%)	0%	113.7	16,141	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Apr 2021	1,500	15,044 (0%)	0%		0	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Controller and PAO	Sale of securities on an exchange or to another person at price $ 120.69 per share.	08 Mar 2021	3,000	13,544 (0%)	0%	120.7	362,070	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Controller and PAO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2021	4,655	4,655	-		-	Stock Option (Right to Buy)
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Controller and PAO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2021	1,560	17,276 (0%)	0%		0	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Controller and PAO	Sale of securities on an exchange or to another person at price $ 138.17 per share.	01 Mar 2021	732	16,544 (0%)	0%	138.2	101,140	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Controller and PAO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.00 per share.	07 Jan 2021	4,000	20,436 (0%)	0%	21	84,000	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Controller and PAO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Jan 2021	4,000	8,000	-		-	Stock Option
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Controller and PAO	Sale of securities on an exchange or to another person at price $ 140.65 per share.	07 Jan 2021	4,000	15,716 (0%)	0%	140.7	562,600	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Controller and PAO	Sale of securities on an exchange or to another person at price $ 87.98 per share.	14 Oct 2020	146	16,436 (0%)	0%	88.0	12,845	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Controller and PAO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.00 per share.	08 Jul 2020	2,000	18,582 (0%)	0%	21	42,000	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Controller and PAO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jul 2020	2,000	12,000	-		-	Stock Option (Right to Buy)
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Controller and PAO	Sale of securities on an exchange or to another person at price $ 91.00 per share.	08 Jul 2020	2,000	16,582 (0%)	0%	91	182,000	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Controller and PAO	Sale of securities on an exchange or to another person at price $ 91.00 per share.	08 Jul 2020	638	16,582 (0%)	0%	91	58,058	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Controller and PAO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jul 2020	1,500	14,000	-		-	Stock Option (Right to Buy)
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Controller and PAO	Sale of securities on an exchange or to another person at price $ 81.00 per share.	01 Jul 2020	1,500	17,220 (0%)	0%	81	121,500	Common Stock
Ultragenyx Pharmaceutical ...	Theodore A. Huizenga	SVP, Controller and PAO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.00 per share.	01 Jul 2020	1,500	18,720 (0%)	0%	21	31,500	Common Stock

Showing 1 to 50 of 59 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades